Promoting Partnerships To Improve Veterans’ Health

Advocacy & Government Relations

NAVREF is an active participant in advocacy efforts to secure robust support for VA research and development.  This entails lobbying for an increase in the annual appropriation of VA medical and prosthetic research account, which is separate from VA health care appropriation.  Also, when warranted, NAVREF works with House and Senate Veterans Affairs Committees to highlight pertinent research and education issues.  Finally, these committees also are critical to the statute that authorizes NPCs.

NAVREF coordinates its funding advocacy efforts with the Friends of VA Medical Care and Health Research (FOVA), a coalition of more than 80 medical specialty, patient advocacy, scientific and academic organizations committed to high quality care for veterans. 

NAVREF Core Advocacy Aspects

NAVREF believes it is time to update our enabling legislation to clarify areas of confusion and/or misinterpretation. We believe these changes will improve the ability of VA-affiliated nonprofit corporations (NPCs) to satisfy Congressional intent to support VA research and education activities and bring greater benefit to Veterans.

Flexible Funding Mechanism – a key aspect of the original legislation is the opening sentence, “The Secretary may authorize the establishment at any Department medical center of a nonprofit corporation to provide a flexible funding mechanism for the conduct of approved research and education at the medical center.” One significant component of this flexibility is the ability of NPCs to accept non-VA appropriated funding under authority of a Memorandum of Agreement (MOA). The statute should be updated to specify that transferring funds from VA to NPC by MOA has the force of a contract in the eyes of the Economy Act for purposes of obligating funds.

Independence – the statute states that an NPC is not “…owned or controlled by the United States” or “an agency or instrumentality of the United States.” However, the VA and other entities frequently question the authority of NPCs to operate independently. For example, the NIH Grants Policy Statement permits academic affiliates the authority to pay principal investigators up to a 60-hour work week, but specifically denies this authority to the NPCs because of a perception of “inter-dependence.” Furthermore, the authority of the Secretary of Veterans Affairs to establish or disestablish a NPC is often cited by VA personnel when imposing controls that limit the flexibility of NPCs. The statute should be updated to specify that while NPCs are clearly related to VA medical centers and designed to support research and education activities at VA medical centers, they remain independent and autonomous nonprofit corporations.

  • 28 Sep 2022 7:18 PM | Anonymous member (Administrator)

    WASHINGTON – Today, U.S. Representatives Diana Harshbarger (R-TN) and Chip Roy (R-TX) introduced the Innovative Cognitive Care For Veterans Act to address the needs of veterans suffering from cognitive impairments through a pilot program initiative. This bill instructs the U.S. Department of Veterans Affairs (VA) to implement a program that partners with private organizations to provide Veterans access to new and innovative care solutions.

    The pilot will launch as a part of the Veterans Community Care Program with the goal of connecting veterans who have cognitive impairments with new and innovative care models. It will also allow for more veterans to age gracefully at home or other appropriate settings, with the freedom of using private partners to obtain the care they need.

    "It is an honor to represent our veterans in Congress. This legislation is part of my mission to improve health care quality and accessibility for our veterans by providing access to telehealth and other innovative technologies that slow the progression of cognitive disorders," said Congresswoman Diana Harshbarger. "As I tell my son and grandsons, when America mourns the lost life of a veteran, we also mourn the loss of their stories, lessons, and patriotism. We owe each hero inexpressible thanks. Given the projected increase in the number of veterans developing cognitive impairments, the VA must explore alternative care models to ensure our veterans and their caregivers have access to top-of-the-line care when and where they need it, a small symbol of gratitude for their career of service and sacrifice. This bill is a step forward."

    "Veterans should have the freedom to avail themselves of the incredible innovative healthcare options that are available in the private sector. This is particularly vital when we consider the growing need for long-term care for our nation’s aging heroes and the myriad challenges and struggles associated with cognitive impairment," said Congressman Chip Roy. "I am proud to stand alongside Rep. Harshbarger and co-sponsor her bill to open up more care options for veterans suffering from cognitive impairment under the VA’s Community Care Program."

    Marlon Ferguson, Chief Executive Officer of National Association of Veterans' Research and Education Foundations:

    “Creating an evolved and inclusive space for veteran cognitive care goes beyond the status quo and puts veterans at the forefront of a transition to an improved form of care. The Innovative Cognitive Care for Veterans Act has potential to be a crucial step forward and we fully support its purpose and mission.”

    Russ Duerstine, Executive Director of Concerned Veterans for America:

    “It’s tragic veterans still don’t have the same options as most Americans regarding where and when they can access health care. The Innovative Cognitive Care for Veterans Act would hold the VA accountable to help veterans access health care in different ways, rather than act as a bureaucratic barrier by keeping them trapped in a failed VA system. CVA supports telehealth which can help thousands of veterans. There are thousands more who need access to dozens of varieties of specialty care, timely and quality specialty care, that need in person treatment. Rep. Harshbarger’s bill would make getting that specialty care a reality for veterans, rather than an exception.” 


    • According to a 2020 study by the Office of the Assistant Deputy Under Secretary for Health for Policy and Planning at the VA, it is projected that the number of VA patients with Alzheimer’s dementia will increase by 28.9 percent between FY 2021 and FY 2033, amounting to an estimated 48,000 new patients with cognitive impairments.
    • VA expenditures for long-term care are growing fast. A GAO reportfrom 2020 estimates that the amount the VA will spend for long-term care is projected to double to $14.3 billion by 2037.
    • As described in the above GAO report, the VA also faces both current and future workforce shortages, and other challenges with providing long-term care services to the more than 2.8 million estimated VA enrolled veterans living in rural areas.
    • As observed by the VA, Veterans can also be prone to unique factors that increase their risk for future cognitive impairment. For example, it has been found that Vietnam-era veterans exposed to Agent Orange are nearly twice as likely as those without exposure to receive a dementia diagnosis. This and other data underscore the need for the U.S. government to do more for Veterans with respect to cognitive care. 

    Participation in the program is limited to the first 500 veterans who apply and are diagnosed with a cognitive disorder associated with aging such as Alzheimer’s, Parkinson’s, or others. The duration of the program would be five years.

    Solicitation of private partners would focus on their ability to support both patients and caregivers at home and through home care agencies. Consideration would be given to partners with experience working with cognitively impaired populations and are capable of providing a level of care that enables Veterans to age at home, if available and appropriate. The Secretary of Veterans Affairs will provide a list of eligible partners based on their application for participation in the program.

    An evaluation of the program will report to the VA Secretary and be distributed to relevant committees in Congress.

    Bill text can be found HERE

    This article originally appeared here:

  • 2 Aug 2022 3:23 PM | Anonymous member (Administrator)

    Senate Appropriations Committee Chair Patrick Leahy (D-Vt.) released all 12 draft FY 2023 Senate appropriations bills this morning, including text of the draft MilCon-VA spending bill and the accompanying explanatory statement and bill summary.

    The bill provides a total of $916 million (+$24 million over FY 2022, +3.85%) for the VA Medical and Prosthetic Research program in FY 2023. This is in alignment with the FY 2023 president’s budget request and falls below the House-passed $926 million investment.

    As a reminder, the Senate draft bills were crafted by the chairs of the 12 subcommittees as the Senate has yet to agree to topline funding for the FY 2023 budget. In his press statement, Leahy noted, “It is my goal to finish our work before the end of the 117th Congress to avoid these consequences.  I look forward to continuing to work with my dear friend, Vice Chairman Shelby, and I encourage good faith, bipartisan negotiations on toplines to resume with the urgency that this moment requires.”

    Leahy added, “Enacting full year bills as soon as possible is imperative.  A long-term continuing resolution, which continues prior fiscal year funding levels, during the record inflationary pressures the country is currently experiencing would result in devastating cuts to programs that the American people rely on and for our national security.” 

    Senate Appropriations Committee Ranking Member Richard Shelby (R-Ala.) issued a press statement in response to the release of the draft FY 2023 bills. “If we are going to get full year bills during this Congress, Democrats must commit to a bipartisan framework that abandons poison pills, preserves legacy riders, and demonstrates a serious commitment to our military. Wasteful, off-budget spending that fuels inflation will be a non-starter.  Today’s effort shows we have a long way to go.  Democrats need to get serious or, regrettably, I believe we will end up with a long-term CR,” Shelby said.

    No additional action in the House or Senate on the FY 2023 spending bills are expected before the chambers recess for the month of August.

  • 20 Jan 2022 4:46 PM | Anonymous member (Administrator)

    The US Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing on December 14 to nominate Dr. Robert Califf as the next FDA Commissioner. Several Senate HELP Committee Republicans following Dr. Califf’s hearing said they would support returning him to the commissioner position—a position he previously held towards the end of the Obama administration. Their support will likely push Califf through a committee vote and, later, a full Senate vote on the nomination. However, it would be fair to note members on both sides of the aisle publicly expressed concerns regarding Dr. Califf’s previous history as FDA Commissioner and with his health and policy work with Google’s parent company, Alphabet.

    A confirmation vote in January would give the FDA a permanent leader for the first time during the Biden administration and perhaps more importantly, during a time when the agency faces several important decisions. Six former FDA commissioners have endorsed Califf's candidacy in a letter to the committee, saying he was committed to public service, advancing science and clinical evidence.

    NAVREF and Dr. Califf crossed paths in 2020 during the NAVREF Annual Conference which was conducted virtually due to the COVID-19 pandemic. During his presentation entitled Evidence Generation - Learning from the Pandemic, he acknowledged his supportive position of VA Research and recognized NAVREF for working closely with VA ORD to advance veterans health research.


    NAVREF is still working with veterans affairs committee staffers to pass key provisions contained in the VIPER Act.  We are cautiously optimistic the provisions will be included in an end of year legislative package focused on veteran issues that will likely be pushed to January. 

    The VIPER Act was introduced on October 25 and aims to improve the VA Medical and Prosthetic Research program by providing additional authority and resources for VA research. NAVREF along with the FOVA executive committee has been working closely with lawmakers to  bring key language to fruition.

    The bill also includes provisions to:

    · Expand the VA’s hiring authority for certain classes of research occupations, including data scientists and statisticians.

    · Create a career development award grant program for researchers at smaller universities.

    · Mandate a Government Accountability Office study on the retention of VA clinician-scientists and the productivity of their research


  • 20 Jul 2021 10:20 AM | Anonymous member (Administrator)

    President’s FY2022 Budget Request – On May 28th the White House released the FY2022 Budget Request.  The Request includes $882 million for VA Research, an increase of 10.9% from the FY2021 enacted level.  See pages 24-26 for more details: 

    FOVA Testimony  - On May 27th, the House Veterans Affairs Committee held a hearing on VA infrastructure. The FOVA Executive Committee (of which NAVREF is a member) submitted the attached written testimony.

  • 29 Jun 2021 10:21 AM | Anonymous member (Administrator)

    Legislative Update – the House FY22 MilCon-VA bill was posted on June 24th and proposed $902M for VA research per the request advocated by the FOVA coalition!  This level of funding is $20 million above the Administration’s request.  NAVREF, as part of The Friends of VA Medical Care and Health Research (FOVA) executive committee, is endorsing $902 million for VA research by submitting a Statement for Record to the Senate Appropriations Subcommittee on Military Construction, Veterans Affairs, and Related Agencies in advance of their upcoming hearing.

  • 25 May 2021 10:20 AM | Anonymous member (Administrator)

    The Friends of VA Medical Care and Health Research Executive Committee submitted a letter to congressional leaders encouraging additional investment in VA research facilities and IT infrastructure.  The letter is posted here:

    The House Veterans Affairs Committee will hold a hearing on VA infrastructure this week

  • 18 May 2021 10:17 AM | Anonymous member (Administrator)
    1. The House Committee on Veterans’ Affairs will hold a hearing on Thursday, May 27th titled, “Investing in a Better VA: Examining the Role of Infrastructure in Veterans’ Access to Care and Benefits.” NAVREF, as part of the Friends of VA, will be submitting public testimony highlighting the infrastructure needs of the VA research facilities.

    b.      The National Science Foundation for the Future Act (H.R.2225) was marked up and reported out of the House Science Research and Technology Subcommittee by a unanimous voice vote. 

    c.       The Schumer/Young Endless Frontier Act was marked up last week by the Senate Commerce Committee.  On Monday, Senators voted to invoke cloture, allowing the measure to move to a floor debate and likely a final vote later this month.

  • 27 Apr 2021 10:17 AM | Anonymous member (Administrator)

    a.            Public Service Announcement.  On April 22, 2021, Senate Veterans’ Affairs Committee Chairman Jon Tester (D-Mont.) and Ranking Member Jerry Moran (R-Kan.) launched a bipartisan public service announcement (PSA) encouraging veterans and their families to get vaccinated. Tester and Moran teamed up with committee members and Veterans Service Organizations — Blinded Veterans Association (BVA), Disabled American Veterans (DAV), The American Legion, Nurses Organization of Veterans Affairs (NOVA), Iraq Afghanistan Veterans Association (IAVA), Military Veterans Advocacy, Vietnam Veterans of America (VVA), as well as Veterans and Military Families for Progress (VMFP) — to highlight the safety and efficacy of the COVID-19 vaccine in a bipartisan effort to increase vaccine confidence among veterans—especially those in rural areas—and help communities recover from the pandemic as quickly as possible.  Click here to watch the Senators’ PSA.

    b.            Foreign Influence.  The Senate Health, Education, Labor and Pensions (SHELP) Committee met April 22 to discuss how to protect US biomedical research from “undue foreign influence.”  Policymakers have long been concerned that other countries, particularly China, are stealing intellectual property resulting from biomedical research conducted in the United States. They point to the relatively large number of foreign graduate students involved in academic research programs. Over the past year, there have been charges of hacking attempts from North Korea to gain access to information concerning the COVID-19 vaccines.

    c.             Veterans’ toxic exposures.  So far, several pieces of legislation have been introduced to expand coverage of veterans’ health conditions that appear to have been caused by toxic exposures. In a Congress with deep, deep political divides, this appears to be the single most bipartisan issue on both sides of the Hill.

    d.            Endless Frontier Act (EFA) Update: Another important development in the R&D arena is the reintroduction (with bipartisan support) of the Schumer/Young Endless Frontier Act. The legislation would add a Technology and Innovation Directorate to NSF and authorize $100 billion for the directorate over five years. The bill would also authorize $10 billion for regional technology hubs. The new bill reflects the recommendations of key science & technology leaders.

  • 6 Apr 2021 10:16 AM | Anonymous member (Administrator)

    a.            Paycheck Protection Program Extension Act – On March 30th, President Biden signed into law the two-month extension to apply for a Paycheck Protection Program (PPP) loan. As a refresher, the legislation extends PPP through May 31. Further, if eligible organizations apply by May 31, the Small Business Administration will permit lenders an additional 30 days to process and approve any outstanding applications.  The maximum loan amount of a second PPP loan is two-and-a-half times the average monthly 2019 or 2020 payroll costs, up to $2 million.  Eligibility criteria for a second PPP loan are as follows:

    • The applicant received a first PPP loan and will or has used the loan only for authorized uses;
    • The applicant employs no more than 300 people; and
    • The applicant can demonstrate at least a 25-percent reduction in gross receipts between comparable quarters in 2019 and 2020.

    b.            The administration’s proposed American Jobs Plan/Build Back Better includes an $18 billion commitment to address VA hospital and clinic infrastructure. 

  • 23 Mar 2021 10:16 AM | Anonymous member (Administrator)
    1. The House passed a bill last week extending the deadline for applying for a loan through the Paycheck Protection Program (PPP) to May 31, and the Senate is expected to take up the legislation as soon as tomorrow. The popular PPP, created by Congress last year and recently expanded to include most 501(c) nonprofit groups, offers forgivable loans to businesses and nonprofits affected by the COVID-19 pandemic.
    2. Both the House and the Senate have overwhelmingly passed a version of the VA Vaccine Act. This legislation authorizes the Department of Veterans Affairs to provide the COVID-19 vaccines to more veterans and to their caregivers.
    3. The Senate HELP Committee and House Energy and Commerce Committee held hearings this week to review the Biden Administration’s pandemic response and ongoing COVID-19 vaccine distribution with CDC Director Dr. Rochelle Walensky, NIH NIAID Director Dr. Anthony Fauci, HHS Chief Scientific Officer for the COVID Response Dr. David Kessler, and FDA CBER Director Dr. Peter Marks.  In their testimonies, the Administration officials underscored how utilizing past scientific discoveries in combination with new partnerships led to the development of COVID-19 vaccines and therapeutics at a record pace. They also spoke to concerns regarding equitable vaccine distribution, and how scientists are navigating emerging variants by modernizing existing research techniques. Addressing “long COVID-19” and the impending mental health crisis exacerbated by the pandemic also remain top priorities.
    4. A new version of the Endless Frontier Act may come to the Senate Floor as early as next month. Based on last year’s bill, the legislation would establish a new directorate at NSF and authorize $100 billion over five years to build out our nation’s technological capacity. You can view the bill from last Congress here and a recent letter from former NSF directors and National Science Board chairs here
    5. March 24 - The House Veterans Affairs Subcommittee on Oversight and Investigations will hold a hearing to examine the VA medical supply chain response to the pandemic.
    March 24 – Senate Committee on Veterans Affairs hearing:  Coping during COVID:  Veterans’ Mental Health and Implementation of the Hannon Act


Together with the Friends of VA Medical Care and Research, NAVREF works with a network of organizations to deliver our message to Congress.

FOVA activities including:

  • Developing recommendations for VA research funding
  • Monitoring the federal budget/appropriations process
  • Meeting with key House and Senate committee members and their staffs
  • Organizing congressional briefings
  •  Maintaining a roster of organizations that endorse FOVA’s funding recommendations
  • Recommending report language on topics of importance to VA research
  • Testifying before the appropriations subcommittees
  • Sending letters to members of Congress at key times during the budget/appropriations cycle

For up-to-date information on the funding needs of VA research and raising awareness of the VA research program, please go to the FOVA website:

1717 K ST NW Suite 900

Washington, DC 20006

202-951-7701  |

FEIN: 52-1784596

Powered by Wild Apricot Membership Software